Investments
44Portfolio Exits
4Funds
9About V-Capital
V-Capital, aka Yicun Capital, is a PE investment institution that focuses on investment discovery, long-term operations as well as integration trading of industry assets services. V-Capital focuses on four industries: Healthcare, TMT and Culture, Integrated Circuit, Alternative Energy & High-end Manufacturing. It operates as a subsidiary of Jiangsu Huaxi Holding.
Latest V-Capital News
Feb 23, 2021
V-Capital, the asset management platform of the publicly-traded textile materials maker Jiangsu Huaxicun, and Hong Kong-listed Software-as-a-Service (SaaS) firm Weimob have joined hands to launch an industry investment fund specialising in data intelligence. The new fund, dubbed “Beijing Weizhi Shuke Investment Centre (Limited Partnership),” has already collected 500 million yuan (USD 77.4 million), said V-Capital in a statement on Monday.
V-Capital Investments
44 Investments
V-Capital has made 44 investments. Their latest investment was in Kangpu Biomedical as part of their Series B - II on August 8, 2023.
V-Capital Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
8/30/2023 | Series B - II | Kangpu Biomedical | $13.74M | Yes | 3 | |
5/5/2023 | Series D - II | VivaVision Biotech | $14.5M | Yes | 1 | |
2/26/2023 | Series A - II | Lanxing Software | Yes | |||
10/22/2022 | Series A | |||||
8/2/2022 | Series B |
Date | 8/30/2023 | 5/5/2023 | 2/26/2023 | 10/22/2022 | 8/2/2022 |
|---|---|---|---|---|---|
Round | Series B - II | Series D - II | Series A - II | Series A | Series B |
Company | Kangpu Biomedical | VivaVision Biotech | Lanxing Software | ||
Amount | $13.74M | $14.5M | |||
New? | Yes | Yes | Yes | ||
Co-Investors | |||||
Sources | 3 | 1 |
V-Capital Portfolio Exits
4 Portfolio Exits
V-Capital has 4 portfolio exits. Their latest portfolio exit was Asieris Pharma on January 07, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
1/7/2022 | IPO | Public | 1 | ||
Date | 1/7/2022 | |||
|---|---|---|---|---|
Exit | IPO | |||
Companies | ||||
Valuation | ||||
Acquirer | Public | |||
Sources | 1 |
V-Capital Fund History
9 Fund Histories
V-Capital has 9 funds, including Beijing Weizhi Shuke Invesment Centre.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
2/23/2021 | Beijing Weizhi Shuke Invesment Centre | $77M | 1 | ||
1/23/2017 | Yaocun Investment Fund | ||||
Kunshan Qicun Investment Center LP | |||||
Yicun Tongwei Angel Fund | |||||
Shanghai Huayi Investment Fund LP |
Closing Date | 2/23/2021 | 1/23/2017 | |||
|---|---|---|---|---|---|
Fund | Beijing Weizhi Shuke Invesment Centre | Yaocun Investment Fund | Kunshan Qicun Investment Center LP | Yicun Tongwei Angel Fund | Shanghai Huayi Investment Fund LP |
Fund Type | |||||
Status | |||||
Amount | $77M | ||||
Sources | 1 |
V-Capital Team
1 Team Member
V-Capital has 1 team member, including current Managing Director, Tao Wang.
Name | Work History | Title | Status |
|---|---|---|---|
Tao Wang | Managing Director | Current |
Name | Tao Wang |
|---|---|
Work History | |
Title | Managing Director |
Status | Current |
Loading...